CARMOT THERAPEUTICS
Carmot Therapeutics provides drugs to treat inflammatory, metabolic, and neurological diseases. They employ their patented technology, Chemotype Evolution, to address the fundamental causes of disease and speed the discovery of disease-modifying therapies. Carmot Therapeutics is headquartered in San Francisco, California and was founded in 2008.
CARMOT THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2008-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.carmot-therapeutics.us
Total Employee:
1+
Status:
Active
Contact:
5105279251
Email Addresses:
[email protected]
Total Funding:
234.85 M USD
Technology used in webpage:
SPF Google Apps For Business Unified Layer BlueHost BlueHost DNS BlueHost Mail
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
Willett Advisors LLC
Willett Advisors LLC investment in Series D - Carmot Therapeutics
Deep Track Capital
Deep Track Capital investment in Series D - Carmot Therapeutics
The Column Group
The Column Group investment in Series D - Carmot Therapeutics
RA Capital Management
RA Capital Management investment in Series D - Carmot Therapeutics
Horizons Ventures
Horizons Ventures investment in Series D - Carmot Therapeutics
Horizons Ventures
Horizons Ventures investment in Series C - Carmot Therapeutics
The Column Group
The Column Group investment in Series C - Carmot Therapeutics
Amgen Ventures
Amgen Ventures investment in Series C - Carmot Therapeutics
The Column Group
The Column Group investment in Series B - Carmot Therapeutics
Horizons Ventures
Horizons Ventures investment in Series B - Carmot Therapeutics
Official Site Inspections
http://www.carmot-therapeutics.us Semrush global rank: 5.15 M Semrush visits lastest month: 1.57 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
